---All---
  • ---All---
  • Accession
  • Catalog #

SH2D4A Antibody (N-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP12049a 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP12049a-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

SH2D4A Antibody (N-term) - Product info

ApplicationWB, IHC
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ9H788
Other AccessionNP_071354.2
ReactivityHuman
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW52727 Da

SH2D4A Antibody (N-term) - Additional info

Gene ID 63898
Other Names
SH2D4A; SH2A; SH2 domain-containing protein 4A; Protein SH(2)A
Target/Specificity
This SH2D4A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 45-75 amino acids from the N-terminal region of human SH2D4A.
Dilution
WB~~1:100~500
IHC~~1:10~50
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
SH2D4A Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.

SH2D4A Antibody (N-term) - Protein Information

Name SH2D4A
Synonyms PPP1R38, SH2A
Function
Inhibits estrogen-induced cell proliferation by competing with PLCG for binding to ESR1, blocking the effect of estrogen on PLCG and repressing estrogen-induced proliferation May play a role in T-cell development and function
Cellular Location
Cytoplasm. Note=Located at podocyte foot processes (By similarity)
Tissue Location
Ubiquitously expressed. Aberrantly expressed in some cancers

SH2D4A Antibody (N-term) - Related products

AP12049a: SH2D4A Antibody (N-term)

RI14835: SH2D4A predesign siRNA

AT3865a: SH2D4A Antibody (monoclonal) (M01)

AF1986a: SH2D4A Antibody

SH2D4A Antibody (N-term) - Application data

  • SH2D4A Antibody (N-term) (Cat. #AP12049a) western blot analysis in NCI-H292 cell line lysates (35ug/lane).This demonstrates the SH2D4A antibody detected the SH2D4A protein (arrow).

  • SH2D4A Antibody (N-term) (Cat. #AP12049a)immunohistochemistry analysis in formalin fixed and paraffin embedded human kidney tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of SH2D4A Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.

SH2D4A Antibody (N-term) - Research Areas

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

SH2D4A inhibits estrogen-induced cell proliferation by competing with PLCG for binding to ESR1, blocking the effect of estrogen on PLCG and repressing estrogen-induced proliferation. May play a role in T-cell development and function.

REFERENCES

Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) : Li, T., et al. BMB Rep 42(8):516-522(2009) Venkatesan, K., et al. Nat. Methods 6(1):83-90(2009) Lapinski, P.E., et al. J. Immunol. 181(3):2019-2027(2008) Sugiyama, N., et al. Mol. Cell Proteomics 6(6):1103-1109(2007)